Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010.
Muraki, Y
Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. [electronic resource] - Infection Apr 2013 - 415-23 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1439-0973
10.1007/s15010-013-0440-0 doi
Amikacin--therapeutic use
Anti-Bacterial Agents--therapeutic use
Ciprofloxacin--therapeutic use
Drug Resistance, Multiple, Bacterial
Drug Utilization--statistics & numerical data
Drug Utilization Review--methods
Hospitals--standards
Humans
Imipenem--therapeutic use
Incidence
Japan--epidemiology
Meropenem
Microbial Sensitivity Tests
National Health Programs
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Retrospective Studies
Surveys and Questionnaires
Thienamycins--therapeutic use
Nationwide surveillance of antimicrobial consumption and resistance to Pseudomonas aeruginosa isolates at 203 Japanese hospitals in 2010. [electronic resource] - Infection Apr 2013 - 415-23 p. digital
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
1439-0973
10.1007/s15010-013-0440-0 doi
Amikacin--therapeutic use
Anti-Bacterial Agents--therapeutic use
Ciprofloxacin--therapeutic use
Drug Resistance, Multiple, Bacterial
Drug Utilization--statistics & numerical data
Drug Utilization Review--methods
Hospitals--standards
Humans
Imipenem--therapeutic use
Incidence
Japan--epidemiology
Meropenem
Microbial Sensitivity Tests
National Health Programs
Pseudomonas Infections--drug therapy
Pseudomonas aeruginosa--drug effects
Retrospective Studies
Surveys and Questionnaires
Thienamycins--therapeutic use